Liquidia (LQDA) FCF Margin (QoQ) (2021 - 2026)
Liquidia (LQDA) FCF Margin (QoQ) (2021 - 2026) Analysis & Trends
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 38.77 Bn | 35.04 Bn | 1.97 Bn |
| 2 | Zoetis | 34.11 Bn | 32.16 Bn | 1.62 Bn |
| 3 | United Therapeutics | 23.68 Bn | 21.53 Bn | 648.10 Mn |
| 4 | Aurora Cannabis | 16.48 Bn | 16.40 Bn | 33.43 Mn |
| 5 | Neurocrine Biosciences | 16.19 Bn | 14.88 Bn | 800.70 Mn |
| 6 | Elanco Animal Health | 11.44 Bn | 11.01 Bn | 785.00 Mn |
| 7 | Alkermes | 7.28 Bn | 6.77 Bn | -116.06 Mn |
| 8 | Lantheus Holdings | 6.48 Bn | 5.98 Bn | 230.92 Mn |
| 9 | Hims & Hers Health | 6.35 Bn | 5.60 Bn | 396.79 Mn |
| 10 | Liquidia | 5.74 Bn | 5.52 Bn | 121.79 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -1,495.00 |
| Dec 31, 2025 | 6,953.00 |
| Sep 30, 2025 | 44,110.00 |
| Jun 30, 2025 | 52,739.00 |
| Mar 31, 2025 | -39,294.00 |
| Dec 31, 2024 | 3,675.00 |
| Sep 30, 2024 | -1,678.00 |
| Jun 30, 2024 | 24,795.00 |
| Mar 31, 2024 | -52,905.00 |
| Dec 31, 2023 | -683.00 |
| Sep 30, 2023 | -20,081.00 |
| Jun 30, 2023 | 6,451.00 |
| Mar 31, 2023 | -10,436.00 |
| Dec 31, 2022 | 9,882.00 |
| Sep 30, 2022 | 2,991.00 |
| Jun 30, 2022 | 6,481.00 |
| Mar 31, 2022 | -4,439.00 |
| Dec 31, 2021 | -5,232.00 |
| Sep 30, 2021 | 6,225.00 |
| Jun 30, 2021 | 15,763.00 |